Lowdell Mark William has filed 17 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 600000 shares of Inmune Bio, Inc. ($INMB) on December 01, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 1, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 26,585,258 | 9999.99% | 2.26% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | D | Stock Option (right to buy) | 400000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 1.50% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 26,585,258 | 9999.99% | 1.50% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | D | Stock Option (right to buy) | 180000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.68% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Stock Option (right to buy) | 180000 | $0.00 | 180,000.0000 | 26,585,258 | 9999.99% | 0.68% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | D | Stock Option (right to buy) | 104000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.39% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Stock Option (right to buy) | 104000 | $0.00 | 104,000.0000 | 26,585,258 | 9999.99% | 0.39% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | D | Stock Option (right to buy) | 140000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.53% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 26,585,258 | 9999.99% | 0.53% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 26,585,258 | 9999.99% | 0.38% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | D | Stock Option (right to buy) | 100000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.38% |
| Dec. 5, 2024 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 20,185,676 | 9999.99% | 0.69% |
| May 14, 2024 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 18,026,473 | 9999.99% | 0.55% |
| April 19, 2024 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | P | Common Stock | 14423 | $8.32 | 1,510,806.0000 | 18,026,473 | 0.96% | 0.08% |
| April 19, 2024 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | P | Common Stock Warrants (right to buy) | 14423 | $0.13 | 14,423.0000 | 18,026,473 | 9999.99% | 0.08% |
| April 19, 2024 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Common Stock | 14423 | $8.32 | 1,510,806.0000 | 18,026,473 | 0.96% | 0.08% |
| April 19, 2024 | Inmune Bio, Inc. | $INMB | Lowdell Mark William | Chief Scientific Officer | A | Common Stock Warrants (right to buy) | 14423 | $0.13 | 14,423.0000 | 18,026,473 | 9999.99% | 0.08% |